provecs is pioneering next-generation tumor gene therapy to expose the tumor to the immune system. The Company´s proprietary enviro adenoviral platform enables the targeted delivery of up to four biologicals combined in one product, thereby activating both the innate and the adaptive immune system. provecs also has established a comprehensive proof-of-concept platform named exviro® for ex-vivo therapy simulation in primary human cancer tissues. exviro®allows the monitoring of immune processes by big data transcriptome profiling, bioinformatics, and tissue immune imaging technologies.
View Top Employees from provecs medical gmbhWebsite | http://www.provecs.com |
Revenue | $4 million |
Employees | 2 (2 on RocketReach) |
Founded | 2007 |
Address | 64 Martinistr., Hamburg, Hamburg 20251, DE |
Phone | +49 40 412632680 |
Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Drug Discovery |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular provecs medical gmbh employee's phone or email?
The provecs medical gmbh annual revenue was $4 million in 2024.
2 people are employed at provecs medical gmbh.
provecs medical gmbh is based in Hamburg, Hamburg.
The NAICS codes for provecs medical gmbh are [325, 32, 32541, 3254].
The SIC codes for provecs medical gmbh are [28, 283].